Wird geladen...

Biomarkers and Surrogate Markers: An FDA Perspective

Summary: Interest is increasing rapidly in the use of surrogate markers as primary measures of the effectiveness of investigational drugs in definitive drug trials. Many such surrogate markers have been proposed as potential candidates for use in definitive effectiveness trials of agents to treat ne...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Katz, Russell
Format: Artigo
Sprache:Inglês
Veröffentlicht: The American Society for Experimental NeuroTherapeutics, Inc. 2004
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC534924/
https://ncbi.nlm.nih.gov/pubmed/15717019
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!